Biologic and Surgical Challenge of Colorectal Hepatic Metastases Dedication to Dr. Leslie Blumgart and Dr. Henri Bismuth
The Neoadjuvant Therapy of Colorectal Hepatic Metastases and the Role of Biologic Sensitizing and Resistance Factors
Pathobiology of Colorectal Cancer Hepatic Metastases With an Emphasis on Prognostic Factors
Optimum Imaging of Colorectal Metastases
Use of Clinical Score to Stage and Predict Outcome of Hepatic Resection of Metastatic Colorectal Cancer
Evolution of Neoadjuvant Therapy for Extended Hepatic Metastases—Have We Reached Our (Non-Resectable) Limit?
Neoadjuvant Therapy of Colorectal Liver Metastases
Biologic Modulation of Chemotherapy in Patients With Hepatic Colorectal Metastases
Optimum Chemotherapy Regimens for Neoadjuvant Therapy of Hepatic Colorectal Metastases
Role of FDG-PET Staging in Selecting the Optimum Patient for Hepatic Resection of Metastatic Colorectal Cancer
Portal Vein Embolization (Prior To Major Hepatectomy) Effects on Regeneration, Resectability, and Outcome
Treatment of Liver Colorectal Metastases
Outcomes of Laparoscopic Hepatic Resection for Colorectal Cancer Metastases
Radiofrequency Ablation of Colorectal Hepatic Metastases†
Role of Intra-Arterial Hepatic Chemotherapy in the Treatment of Colorectal Cancer Metastases†
Extending Limits of Resection for Metastatic Colorectal Cancer
Optimizing Resection for “Responding” Hepatic Metastases After Neoadjuvant Chemotherapy